Document Detail

Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
MedLine Citation:
PMID:  25267165     Owner:  NLM     Status:  Publisher    
OBJECTIVES: Higher risk of lung cancer has been noted in patients with type 2 diabetes mellitus (DM). Some observational studies have shown a reduced risk of lung cancer in DM patients taking metformin, but a dose-response relationship has never been reported. The aim of this study is to exam the association between the dose of metformin and the incidence of lung cancer in a Chinese population.
MATERIALS AND METHODS: The dataset used for this nationwide population-based study is a cohort of 1 million subjects randomly sampled from individuals enrolled in the Taiwan National Health Insurance system. We enrolled all subjects with newly diagnosed type 2 DM between 1997 and 2007. Subjects with a diagnosis of neoplasm before DM diagnosis, those using metformin before DM diagnosis, those with polycystic ovary syndrome, and those with a DM diagnosis before their 15 years of age were excluded. The demographic data and duration, cumulative dose and intensity of metformin use were compared between patients developing lung cancer and those without lung cancer.
RESULTS: Totally, 47,356 subjects were identified. After adjusting for age, gender, and modified Charlson Comorbidity Index score, the utilization of metformin was an independent protecting factor, and the risk of developing lung cancer decreased progressively with either the higher cumulative dose or the higher intensity of metformin use.
CONCLUSIONS: This study revealed that the use of metformin decreased the risk of lung cancer in a dose-dependent manner in patients with type 2 DM. The chemo-preventive effect of metformin deserves further study.
Ming-Ju Tsai; Chih-Jen Yang; Ya-Ting Kung; Chau-Chyun Sheu; Yu-Ting Shen; Pi-Yu Chang; Ming-Shyan Huang; Herng-Chia Chiu
Related Documents :
25208515 - Patterns of psychiatric medication use among nationally representative long-term cancer...
25456995 - Enhanced antitumor efficacy of vitamin e tpgs-emulsified plga nanoparticles for deliver...
16518375 - Targeting multidrug resistance in cancer.
19023615 - Nonviral delivery for genomic therapy of cancer.
21479445 - Direct evidence that heterogeneity necessitates and limits the use of multidrug chemoth...
16171485 - Wrigley forceps to deliver a bulky uterus following a total laparoscopic hysterectomy f...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-22
Journal Detail:
Title:  Lung cancer (Amsterdam, Netherlands)     Volume:  -     ISSN:  1872-8332     ISO Abbreviation:  Lung Cancer     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-30     Completed Date:  -     Revised Date:  2014-10-1    
Medline Journal Info:
Nlm Unique ID:  8800805     Medline TA:  Lung Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bullying among school-age children in the greater Beirut area: Risk and protective factors.
Next Document:  A population-based study of the resource utilization and costs of managing resectable non-small cell...